This HTML5 document contains 185 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n16	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n3	http://linked.opendata.cz/ontology/sukl/
n13	http://linked.opendata.cz/resource/sukl/specialization-restriction/
skos	http://www.w3.org/2004/02/skos/core#
n5	http://linked.opendata.cz/resource/sukl/indgroup/
n14	http://linked.opendata.cz/resource/sukl/packing/
n17	http://linked.opendata.cz/resource/sukl/company/
n19	http://linked.opendata.cz/resource/sukl/active-ingredient/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0130137/price-of-originator/
n10	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0130137/reimbursement/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://linked.opendata.cz/resource/sukl/registration-state/
n12	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0130137/
n15	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0130137/core-reimbursement/
xsdh	http://www.w3.org/2001/XMLSchema#
n20	http://www.sukl.cz/modules/medication/
n6	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0130137/price/
n18	http://linked.opendata.cz/resource/atc/
n7	http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item

n2:0130137

rdf:type

n3:MedicinalProductPackaging

dcterms:title

IRINOTECAN MYLAN 20 MG/ML

skos:notation

0130137

n3:hasATCCode

n18:L01XX19

n3:hasActiveIngredient

n19:IRINOTECANI-HYDROCHLORIDUM-TRIHYDRICUM

n3:hasDefinedDailyDose

n12:ddd

n3:hasDosageForm

n7:CNC-SOL-INF

n3:hasPackagingSize

1X2ML

n3:hasPacking

n14:VIA

n3:hasRegistrationHolder

n17:MYSF

n3:hasRegistrationState

n11:R

n3:hasRouteOfAdministration

n16:INF

n3:hasStrength

20MG/ML

n3:hasIndicationGroup

n5:44

n3:hasSpecializationRestriction

n13:ONK

n3:containsDefinedDailyDoses

0.0

n3:hasRegistrationCode

44/ 011/09-C

n3:hasTitleSupplement

INF CNC SOL 1X2ML/40MG

n3:containsUsualTherapeuticalDailyDoses

1.3874 1.7983

n3:hasCoreReimbursementSpecification

n15:2015-01-13 n15:2015-02-01 n15:2014-12-01 n15:2015-01-01 n15:2015-04-02 n15:2015-05-01 n15:2015-03-01 n15:2015-04-01 n15:2015-07-02 n15:2015-06-01 n15:2015-07-01 n15:2014-02-01 n15:2014-03-01 n15:2013-12-01 n15:2014-01-01 n15:2014-06-01 n15:2014-06-13 n15:2014-04-01 n15:2014-05-01 n15:2014-08-01 n15:2014-09-01 n15:2014-07-01 n15:2014-07-03 n15:2014-11-01 n15:2014-11-19 n15:2014-10-01 n15:2014-10-02 n15:2013-01-01 n15:2013-03-01 n15:2013-04-01 n15:2013-01-05 n15:2013-02-01 n15:2013-07-01 n15:2013-08-01 n15:2013-05-01 n15:2013-06-01 n15:2013-10-01 n15:2013-11-01 n15:2013-08-03 n15:2013-09-01

n3:hasIndicationRestriction

P

n3:hasPriceOfOriginatorSpecification

n4:2013-01-01 n4:2014-06-01 n4:2014-06-13 n4:2014-04-01 n4:2014-05-01 n4:2014-02-01 n4:2014-03-01 n4:2013-12-01 n4:2014-01-01 n4:2013-10-01 n4:2013-11-01 n4:2013-08-03 n4:2013-09-01 n4:2013-07-01 n4:2013-08-01 n4:2013-05-01 n4:2013-06-01 n4:2015-04-02 n4:2015-05-01 n4:2015-03-01 n4:2015-04-01 n4:2015-01-13 n4:2015-02-01 n4:2014-12-01 n4:2015-01-01 n4:2014-11-01 n4:2014-11-19 n4:2014-10-01 n4:2014-10-02 n4:2014-08-01 n4:2014-09-01 n4:2014-07-01 n4:2014-07-03 n4:2015-07-02 n4:2015-06-01 n4:2015-07-01 n4:2013-03-01 n4:2013-04-01 n4:2013-01-05 n4:2013-02-01

n3:hasPriceSpecification

n6:2013-05-01 n6:2013-06-01 n6:2013-07-01 n6:2013-08-01 n6:2013-08-03 n6:2013-09-01 n6:2013-10-01 n6:2013-11-01 n6:2013-01-01 n6:2013-01-05 n6:2013-02-01 n6:2013-03-01 n6:2013-04-01 n6:2014-07-01 n6:2014-07-03 n6:2014-08-01 n6:2014-09-01 n6:2014-10-01 n6:2014-10-02 n6:2014-11-01 n6:2014-11-19 n6:2013-12-01 n6:2014-01-01 n6:2014-02-01 n6:2014-03-01 n6:2014-04-01 n6:2014-05-01 n6:2014-06-01 n6:2014-06-13 n6:2015-06-01 n6:2015-07-01 n6:2015-07-02 n6:2014-12-01 n6:2015-01-01 n6:2015-01-13 n6:2015-02-01 n6:2015-03-01 n6:2015-04-01 n6:2015-04-02 n6:2015-05-01

n3:hasReimbursementSpecification

n10:2013-01-01 n10:2013-03-01 n10:2013-04-01 n10:2013-01-05 n10:2013-02-01 n10:2014-02-01 n10:2014-03-01 n10:2013-12-01 n10:2014-01-01 n10:2014-06-01 n10:2014-06-13 n10:2014-04-01 n10:2014-05-01 n10:2013-07-01 n10:2013-08-01 n10:2013-05-01 n10:2013-06-01 n10:2013-10-01 n10:2013-11-01 n10:2013-08-03 n10:2013-09-01 n10:2015-01-13 n10:2015-02-01 n10:2014-12-01 n10:2015-01-01 n10:2015-04-02 n10:2015-05-01 n10:2015-03-01 n10:2015-04-01 n10:2014-08-01 n10:2014-09-01 n10:2014-07-01 n10:2014-07-03 n10:2014-11-01 n10:2014-11-19 n10:2014-10-01 n10:2014-10-02 n10:2015-07-02 n10:2015-06-01 n10:2015-07-01

n3:hasResumedMarketingDate

2009-12-01+01:00

n3:hasUsualTherapeuticalDailyDose

n12:utdd

n3:spcFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC50608.pdf%26type%3Dspc%26as%3Dirinotecan-mylan-20-mg-ml-spc

n3:spcUri

n20:download.php?file=SPC50608.pdf&type=spc&as=irinotecan-mylan-20-mg-ml-spc